Biotech startups in Seattle, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Avalyn Pharma | Seattle | Series D | $100.0M | 2025-07-22 |
| InduPro | Seattle | Series B | $77.0M | 2026-08-12 |
| Talus Bio | Seattle | Seed | $11.2M | 2026-09-21 |
| Parse Biosciences | Seattle | Series C | $50.0M | 2023-12-14 |
| Umoja Biopharma | Seattle | Series C | $100.0M | 2025-01-14 |
| Curi Bio | Seattle | Series B | $10.0M | 2025-12-02 |
| ZipBio | Seattle | Seed | $4.0M | 2024-09-05 |
| ProfoundBio | Seattle | Series B | $112.0M | 2024-02-13 |
8 rows of the CSV in 5 of its 18 columns.
- The 86 biotech startups in Seattle, United States have raised $4.5B in total.
- 10 of them closed their most recent round in the last 12 months, $278.4M combined.
- The largest of those rounds is BrainChild Bio's $116.0M Series A, dated September 2026.
- The most recent is Strella Biotechnology's $4.2M Series A on 23 October 2026.
- Alexandria Venture Investments is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 69 companies (80%).
- 30% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (44% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
9 of 86| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Talus Bio | Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. | Artificial intelligence | Seed | $11.2M | 2026-09-21 | $27.8M | Y Combinator, Pioneer Fund, National Science Foundation +2 | 11 to 50 | 2020 |
| InduPro | InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. | Biotech | Series B | $77.0M | 2026-08-12 | $162.0M | Euclidean Capital, The Column Group, Vida Ventures +1 | 51 to 100 | 2022 |
| Curi Bio | Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. | Artificial intelligence | Series B | $10.0M | 2025-12-02 | $30.4M | National Institutes of Health, Dynamk Capital | 11 to 50 | 2015 |
| Lumen Bioscience | Lumen Bioscience discovers, develops, and manufactures biologic drugs and vaccine candidates. | Biotech | Series C | $30.0M | 2025-10-08 | $97.0M | US Department of Energy, WestRiver Group | 101 to 250 | 2017 |
| Avalyn Pharma | Avalyn Pharma develops therapies for idiopathic pulmonary fibrosis and other respiratory diseases. | Biotech | Series D | $100.0M | 2025-07-22 | $372.5M | Eight Roads Ventures, F-Prime, Wellington Management +2 | 11 to 50 | 2011 |
| Umoja Biopharma | Umoja Biopharma develops immunotherapies intended to treat cancer by engineering the body's own immune cells. | Biotech | Series C | $100.0M | 2025-01-14 | $363.0M | SoftBank Vision Fund, Temasek, Cormorant Asset Management +2 | 101 to 250 | 2019 |
| ZipBio | ZipBio develops gene therapies using machine learning, protein engineering, and molecular materials. | Biotech | Seed | $4.0M | 2024-09-05 | $4.0M | NFX, MoreVC | 1 to 10 | 2022 |
| Parse Biosciences | Parse Biosciences develops single-cell sequencing kits for researchers. | Biotech | Series C | $50.0M | 2023-12-14 | $100.0M | National Science Foundation, Marshall Wace, Horizon Technology Finance +2 | 101 to 250 | 2018 |
| Genemod | Genemod provides a unified platform for life scientists to collaborate and manage lab operations. | Biotech | Seed | $4.5M | 2023-05-01 | $8.2M | Unpopular Ventures, Canaan Partners, Amino Capital +2 | 11 to 50 | 2018 |
Table 1. Biotech startups in Seattle, United States: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 86.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | InduPro | InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. | Biotech | Series B | $77.0M | 2026-08-12 | $162.0M | Euclidean Capital, The Column Group, Vida Ventures +1 | 51 to 100 | 2022 |
| 2 | Talus Bio | Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. | Artificial intelligence | Seed | $11.2M | 2026-09-21 | $27.8M | Y Combinator, Pioneer Fund, National Science Foundation +2 | 11 to 50 | 2020 |
| 3 | Curi Bio | Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. | Artificial intelligence | Series B | $10.0M | 2025-12-02 | $30.4M | National Institutes of Health, Dynamk Capital | 11 to 50 | 2015 |
Table 2. Biotech startups in Seattle, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 3 | 3% | ||
| 2 | Madrona | Venture capital firm | Seattle, United States | 3 | 3% | ||
| 3 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | 2 | 2% | 2 | Talus Bio, Curi Bio |
| 4 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 2 | 2% | 1 | Talus Bio |
| 5 | RA Capital Management | Startup incubator | Boston, United States | 2 | 2% | ||
| 6 | OrbiMed | Private equity firm | New York, United States | 2 | 2% | ||
| 7 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 2 | 2% | ||
| 8 | Wellington Management | Private equity firm | Boston, United States | 1 | 1% | ||
| 9 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 1 | 1% | ||
| 10 | F-Prime | Venture capital firm | Cambridge, United States | 1 | 1% | ||
| 11 | Perceptive Advisors | Hedge fund | New York, United States | 1 | 1% | ||
| 12 | Andera Partners | Private equity firm | Paris, France | 1 | 1% | ||
| 13 | Euclidean Capital | Family office | New York, United States | 1 | 1% | 1 | InduPro |
| 14 | MRL Ventures Fund | Corporate venture arm | Cambridge, United States | 1 | 1% | 1 | InduPro |
| 15 | Vida Ventures | Venture capital firm | Boston, United States | 1 | 1% | 1 | InduPro |
Table 3. Biotech startups in Seattle, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 69 | 80% | $4.0B |
| Software | 15 | 17% | $180.0M |
| Artificial intelligence | 10 | 12% | $98.9M |
| Hardware | 3 | 3% | $26.0M |
| Commerce | 1 | 1% | $4.4M |
Table 4. Biotech startups in Seattle, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in Seattle, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 10% | $4.2M |
| September 2026 | 5 | 50% | $128.9M |
| August 2026 | 1 | 10% | $77.0M |
| June 2026 | 1 | 10% | $46.0M |
| December 2025 | 2 | 20% | $22.3M |
Table 6. Biotech startups in Seattle, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 9% | $256.1M |
| 2025 | 11 | 13% | $472.0M |
| 2024 | 7 | 8% | $285.6M |
| 2023 | 10 | 12% | $153.3M |
| 2022 | 9 | 10% | $199.5M |
| 2021 | 9 | 10% | $278.7M |
Table 7. Biotech startups in Seattle, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 8% |
| 2020 to 2022 | 18 | 21% |
| 2015 to 2019 | 28 | 33% |
| 2010 to 2014 | 17 | 20% |
| Before 2010 | 14 | 17% |
Table 8. Biotech startups in Seattle, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 37 | 44% |
| 11 to 50 | 33 | 39% |
| 51 to 100 | 7 | 8% |
| 101 to 250 | 5 | 6% |
| 251 to 500 | 1 | 1% |
| 501 to 1,000 | 1 | 1% |
Table 9. Biotech startups in Seattle, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Seattle, United States. On 16 November 2026 that is 86 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 9 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 86 rows: 13 have no round amount, 0 no city and 19 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Seattle, United States are on the list?
- 86, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 86 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.